Arcxis Gets $2.25M In Funding

Pleasanton-based Arcxis Biotechnologies, a biomedical device firm developing products for rapid diagnostics, pathogen handling, and sample preparation, has raised $2.25M in Series A funding. The funding came from Claremont Creek Ventures. Arcxis said it would use the funding to hire key employee talent, make equipment purchases, and initiate commercial development programs. More information »